Autologous stem cell transplant for light chain deposition disease: incorporating bortezomib to the induction therapy

Am J Hematol. 2012 Aug;87(8):822-3. doi: 10.1002/ajh.23235. Epub 2012 May 28.
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin Light Chains*
  • Male
  • Paraproteinemias / mortality
  • Paraproteinemias / therapy*
  • Pyrazines / administration & dosage*
  • Retrospective Studies
  • Stem Cell Transplantation*
  • Survival Rate
  • Transplantation, Autologous

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Immunoglobulin Light Chains
  • Pyrazines
  • Bortezomib